an Experimental Test of the Relationship between Electronic Nicotine Delivery System Use and alcohol Consumption.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
hershberger (2021)
age-Varying associations Between attempts to Lose Weight and Nicotine Vaping across adolescence: Results From a Nationally Representative Sample.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
hochgraf (2023)
Systematic review on e-cigarette and its effects on weight gain and adipocytes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
hod (2022)
The interaction of nicotine concentration and device power on electronic nicotine delivery system (ENDS) abuse liability among exclusive ENDS users and dual users of ENDS and combustible cigarettes.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
hoetger (2022)
Effects of Device Settings and E-Liquid Characteristics on Mouth-Throat Losses of Nicotine Delivered with Electronic Nicotine Delivery Systems (ENDS).
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
hosseini (2023)
Exposure, Retention, Exhalation, Symptoms, and Environmental accumulation of Chemicals During JUUL Vaping.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
hua (2023)
Trends and associated risks in adolescent substance use: E-cigarette use and nitrous oxide use.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
huizink (2022)
Vaping for weight control: a cross-sectional population study in England.
Individual Clinical
Pharmacokinetics & Abuse Liability
Misuse Potential
Jackson (2019)
Is the use of e-cigarettes for smoking cessation associated with alcohol consumption?
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Jackson (2020)
Nicotine pharmacokinetics of electronic cigarettes: a pooled data analysis from the literature.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharamacokinetics
Jacobson (2021)